MorphoSys AG voluntarily delists from Nasdaq, focusing on European investors and Frankfurt Stock Exchange.
MorphoSys AG announces its voluntary delisting from the Nasdaq Global Market. The company cites operational and financial reasons behind the decision, including a focus on European investors and market conditions. MorphoSys plans to continue trading on the Frankfurt Stock Exchange. The delisting is scheduled to take effect on September 23, 2024.
July 12, 2024
4 Articles